Buy Vfend
Vfend

31.2
Vfend (Voriconazole) is an azole antifungal medication used to treat serious fungal infections such as invasive aspergillosis or candidemia. It works by stopping the growth of fungi by inhibiting the synthesis of ergosterol, an essential component of the fungal cell wall.


Ingredient
Category
Availability
In Stock
Delivery Time
Airmail (14-21 days) | EMS trackable (5-9 days)
Product is shipped in a fully discreet envelope with no content disclosure, including all required documentation inside

Product Sheet

Active Ingredient(s)
Voriconazole
Manufacturer
Pfizer
Product Form
Tablet, Oral suspension, Infusion
Regulatory Classification
Rx
Primary Category
Fungal Infection
Product Category
Antimycotics for systemic use, Triazole derivatives
Pharmacological Class
Triazole antifungal
Manufacturer Description
A broad-spectrum antifungal medication used to treat life-threatening fungal infections.
Mechanism of Action
Voriconazole inhibits the synthesis of ergosterol, a vital component of the fungal cell membrane. This prevents the fungus from maintaining its structure and growing, eventually killing it.
Route of Administration
Oral
Onset Time
1-2 hours
Duration
12 hours
Contraindications
Coadministration with CYP3A4 substrates (e.g., Terfenadine), Severe liver disease
Severe Adverse Events
Severe liver damage, Kidney failure, Stevens-Johnson syndrome, Cardiac arrhythmia
Common Side Effects
Visual disturbances, Fever, Nausea
Uncommon Side Effects
Skin rash, Vomiting, Liver function test abnormalities
Drug Interactions
Rifampicin, Carbamazepine, St John's wort, Statins, Warfarin
Pregnancy Safety Warnings
Not to be used during pregnancy unless the benefit clearly outweighs the risk.
Age Restrictions
Adults and children over 2 years
Storage Guidelines
Store tablets at room temperature.
Related Products
Itraconazole, Fluconazole, Amphotericin B

Vfend FAQ

What should I avoid eating while taking Vfend?

There are no specific foods that must be avoided, but grapefruit juice can increase voriconazole levels by inhibiting CYP3A4. It is safest to limit grapefruit consumption during therapy.

Can I travel internationally with Vfend tablets?

Yes, Vfend tablets are permitted for personal medical use in most countries, but you should carry the original prescription label and a copy of the prescribing information. Check the destination country's customs regulations for any restrictions on prescription medicines.

How does the appearance of Vfend tablets help identify them?

Vfend 200 mg tablets are round, white, and imprinted with “V” on one side and “200” on the other. The imprint aids pharmacists and patients in confirming the correct medication.

Is a urine drug test likely to detect Vfend?

Standard workplace drug screens do not test for voriconazole, so Vfend use is unlikely to be identified in routine urine tests.

Can Vfend be taken with oral contraceptives?

Voriconazole can increase the plasma concentration of hormonal contraceptives, potentially enhancing side effects but also providing reliable contraception. No dosage adjustment is required, but discuss any concerns with your clinician.

What is the typical duration of treatment for invasive aspergillosis?

Therapy often lasts 6-12 weeks, but the exact length depends on the infection’s severity, site, and patient response. Your healthcare team will determine the appropriate duration.

Are there any known differences between Vfend and generic voriconazole?

Both contain the same active ingredient, voriconazole, and are required to meet the same bio-equivalence standards. The primary differences lie in inactive ingredients and branding, which rarely affect clinical efficacy.

How is voriconazole cleared in patients with kidney failure?

The oral formulation is largely metabolised by the liver; renal clearance is minimal. However, the intravenous formulation contains a cyclodextrin vehicle that can accumulate in severe renal impairment, so oral tablets are preferred in this population.

What visual changes might signal a serious problem?

If you experience sudden loss of vision, photophobia, or persistent colour distortion, seek medical attention promptly, as these may indicate severe neuro-ophthalmic toxicity.

Does Vfend interact with common over-the-counter supplements?

St. John’s wort is a strong CYP3A4 inducer and can lower voriconazole levels, reducing its effectiveness. It is advisable to avoid this supplement while on Vfend.

What is Vfend?

Vfend is a prescription antifungal medication that contains the active ingredient voriconazole. It is marketed as oral tablets (pill) in a 200 mg strength and is used to treat serious fungal infections. In the United Kingdom, Vfend is classified as a prescription-only medicine (POM) and is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).

How Vfend Works in the Body

Voriconazole belongs to the triazole class of antifungals. It works by inhibiting the fungal enzyme lanosterol 14α-demethylase, an essential component of the ergosterol synthesis pathway. Ergosterol is a key structural lipid in fungal cell membranes; without it, the membrane becomes unstable, leading to impaired growth and eventual cell death.

Key pharmacologic points:

  • Onset of action: Clinical effect typically begins within a few days of therapy.
  • Peak plasma concentration: Reached 1-2 hours after oral ingestion of a 200 mg tablet.
  • Half-life: Approximately 6 hours in healthy adults, but can be longer in patients with hepatic impairment.
  • Metabolism: Primarily through the cytochrome P450 enzymes CYP2C19, CYP2C9, and CYP3A4, which also underlie many drug-drug interactions.

Conditions Treated by Vfend

Vfend is approved in the UK for the treatment of the following invasive fungal infections:

  • Invasive aspergillosis (including pulmonary and sinus disease)
  • Infections caused by Scedosporium species and Fusarium species
  • Empiric therapy for suspected fungal infections in severely immunocompromised patients (e.g., those undergoing hematopoietic stem-cell transplantation)

These indications are based on the product’s assessment by the MHRA and supported by clinical trials demonstrating efficacy against the listed pathogens.

Off-Label and Investigational Applications

Evidence from peer-reviewed studies suggests that voriconazole has activity against other mould infections such as Lomentospora prolificans and certain Candida species. However, these uses are not approved by the MHRA and should only be considered when a specialist determines that the potential benefits outweigh the risks.

Off-label use requires medical supervision and individualized risk assessment.

Who Should Not Use Vfend?

Absolute Contraindications

  • Known hypersensitivity to voriconazole or any other azole antifungal.
  • Co-administration with:
  • Rifampicin or rifabutin (potent inducers of CYP enzymes that markedly reduce voriconazole levels).
  • Ergot-derived drugs (risk of severe vasospasm).

Relative Contraindications

  • Severe hepatic impairment (Child-Pugh class C) - dose adjustment and close monitoring required.
  • Pregnancy - voriconazole is classified as Pregnancy Category D (risk of fetal harm). It should be avoided unless no suitable alternatives exist.
  • Lactation - voriconazole is excreted in breast milk; breastfeeding is not recommended while on therapy.

Special Populations

  • Elderly patients may experience higher plasma concentrations; dose may need reduction.
  • Patients with renal impairment do not require routine dose adjustment, but those on haemodialysis should be monitored for accumulation of the vehicle (cyclodextrin).

Safety Profile: Side Effects and Interactions

Common Side Effects

  • Visual disturbances (blurred vision, altered colour perception) - often transient and occur within the first few days.
  • Skin rash or mild pruritus.
  • Elevated liver enzymes - usually reversible on discontinuation.
  • Nausea, vomiting, or abdominal discomfort.

Serious Adverse Events

  • Severe hepatotoxicity - may present with jaundice, dark urine, or right-upper-quadrant pain; requires immediate medical attention.
  • Photosensitivity reactions - can lead to severe sunburn; patients should avoid prolonged UV exposure.
  • QT interval prolongation - may precipitate cardiac arrhythmias, especially in patients with pre-existing cardiac disease or when combined with other QT-prolonging agents.

Drug Interactions

  • Major interactions (require dose adjustment or avoidance):
  • CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) - increase voriconazole levels.
  • CYP3A4 inducers (e.g., carbamazepine, phenytoin) - decrease voriconazole levels.
  • Statins (especially simvastatin) - heightened risk of myopathy; consider switching statin or monitoring CK.
  • Moderate interactions (monitoring advised):
  • Warfarin - may enhance anticoagulant effect; monitor INR more frequently.
  • Phenytoin - can lower voriconazole concentrations; adjust antifungal dose as needed.

Food and Lifestyle Interactions

  • Alcohol: No direct contraindication, but excessive intake can worsen liver toxicity.
  • Grapefruit juice: Inhibits CYP3A4 and may raise voriconazole concentrations; patients should avoid large quantities.
  • Driving and machinery: Visual disturbances can impair ability to operate vehicles; patients should be cautioned until they know how the drug affects them.

Patients should always provide a complete medication list, including over-the-counter products and herbal supplements, to their healthcare provider before starting Vfend.

How to Take Vfend

  • Standard dosing for invasive aspergillosis:
  • Loading phase: 400 mg (two 200 mg tablets) every 12 hours for the first 24 hours.
  • Maintenance phase: 200 mg every 12 hours thereafter.
  • Duration of therapy is guided by clinical response and may range from several weeks to months.
  • Special populations:
  • Mild to moderate hepatic impairment (Child-Pugh A or B): Consider reducing the maintenance dose to 200 mg once daily.
  • Severe hepatic impairment: Use only if benefits clearly outweigh risks; close therapeutic drug monitoring (TDM) is advised.
  • Administration tips:
  • Swallow tablets whole with a full glass of water.
  • Can be taken with or without food; a light meal may reduce gastrointestinal upset.
  • Missed dose: Take the missed tablet as soon as remembered unless it is near the time of the next dose. Do not double-dose.
  • Overdose: Symptoms may include severe nausea, vomiting, visual changes, and liver dysfunction. Seek emergency medical care; activated charcoal may be considered if presentation is early.
  • Discontinuation: Abrupt cessation is generally safe, but for prolonged therapy tapering may be recommended to avoid rebound fungal growth. Follow the prescribing clinician’s advice.

Monitoring and Follow-Up

  • Liver function tests (ALT, AST, bilirubin) should be measured before initiation and at least weekly for the first month, then periodically.
  • Therapeutic drug monitoring: Voriconazole plasma concentrations are often checked to maintain levels between 1-5 µg/mL, reducing risk of toxicity while ensuring efficacy.
  • Visual assessment: Patients should report any new visual changes promptly.
  • Electrolytes and renal function: Baseline and periodic monitoring are advisable, especially in patients receiving intravenous formulations that contain cyclodextrin.

Regular follow-up appointments with the prescribing clinician are essential to adjust dosing based on laboratory results and clinical response.

Storage and Handling

  • Keep tablets in the original container, tightly closed.
  • Store at room temperature (15-30 °C), protected from light and moisture.
  • Do not use tablets after the expiry date printed on the package.
  • Keep out of reach of children; consider a child-proof lockbox.
  • Unused medication should be disposed of via a pharmacy take-back service or according to local NHS waste-disposal guidelines.

Medication-Specific Glossary

Cytochrome P450
A family of liver enzymes that metabolise many drugs; voriconazole is primarily processed by CYP2C19, CYP2C9, and CYP3A4.
Therapeutic Drug Monitoring (TDM)
Measurement of drug concentrations in the blood to ensure they remain within a target therapeutic range.
QT Prolongation
Lengthening of the heart’s electrical repolarisation interval, which can predispose to arrhythmias.
Ergosterol
The fungal analogue of cholesterol; inhibition of its synthesis disrupts fungal cell membrane integrity.
Loading Dose
An initial higher dose of medication designed to rapidly achieve therapeutic blood levels.

Medical Disclaimer

This article provides educational information about Vfend and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.

Information for Vfend is sourced from established medical standards and updated frequently. It is provided for general guidance and should be confirmed with a healthcare professional before use.
Categories
Waar kunt u Haar & Huidverzorging veilig aanschaffen - Diane 35 pil online Order medications for Mental Health Antidepressants: - Effexor Price